Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by aldo451on Jan 11, 2019 8:03pm

553 Views

Post# 29221752

RE:Fred Dumais

He was in San Fran, here is part of his reply I received late this afternnon...

Just back today from SF attending the JP Morgan conference. Very good set of meetings. 3 tracks every day with BD discussions with pharma companies, bankers, analysts and investors. Our interim CEO is extremely focused and dedicated to making sure the partnering process moves as quickly as possible as well as fixing the balance sheet.